发明授权
- 专利标题: Asymmetric catalytic reduction of oxcarbazepine
- 专利标题(中): 不对称催化还原奥卡西平
-
申请号: EP11152286.8申请日: 2006-04-21
-
公开(公告)号: EP2319836B1公开(公告)日: 2015-11-25
- 发明人: Learmonth, David Alexander , Grasa, Gabriela Alexandra , Zanotti-Gerosa, Antonio
- 申请人: Bial-Portela & CA, S.A.
- 申请人地址: À Avenida da Siderurgia Nacional 4745-457 S. Mamede do Coronado PT
- 专利权人: Bial-Portela & CA, S.A.
- 当前专利权人: Bial-Portela & CA, S.A.
- 当前专利权人地址: À Avenida da Siderurgia Nacional 4745-457 S. Mamede do Coronado PT
- 代理机构: Cottrill, Emily Elizabeth Helen
- 优先权: GB0515690 20050729
- 主分类号: C07D223/22
- IPC分类号: C07D223/22
摘要:
A process for preparing (S)-(+)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide or (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide, by reduction of oxcarbazepine in the presence of a catalyst and a hydride source is disclosed. The catalyst is prepared from a combination of [RuX 2 (L)] 2 wherein X is chlorine, bromine or iodine, and L is an aryl or aryl-aliphatic ligand, with a ligand of formula (A) or formula (B): wherein R 1 is chosen from C 1-6 alkoxy and C 1-6 alkyl, n is a number from 0 to 5, and when n is a number from 2 to 5, R 1 can be the same or different, and R 2 is alkyl, substituted alkyl, aryl, substituted aryl, alkaryl or substituted alkaryl. The hydride source is either NR 3 R 4 R 5 and formic acid, [R 3 R 4 R 5 NH][OOCH] and optionally formic acid, or [M][OOCH] x and formic acid, wherein R 3 , R 4 and R 5 are C 1-6 alkyl, M is an alkali metal or alkaline earth metal and x is 1 or 2. A pH from 6.5 to 8 is maintained during the process.
公开/授权文献
- EP2319836A1 Asymmetric catalytic reduction of oxcarbazepine 公开/授权日:2011-05-11
信息查询